Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
CONCLUSION: The ALBI score accurately identifies decompensation risk at the 3-year follow-up in patients with compensated cirrhosis. Those cirrhotic patients with a high-risk grade of ALBI score showed a 23 times greater odds of decompensation.PMID:37701131 | PMC:PMC10494764 | DOI:10.3748/wjg.v29.i32.4873
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Huttakan Navadurong Kessarin Thanapirom Salisa Wejnaruemarn Thaninee Prasoppokakorn Roongruedee Chaiteerakij Piyawat Komolmit Sombat Treeprasertsuk Source Type: research
More News: Bilirubin | Bleeding | Cancer & Oncology | Carcinoma | Child Development | Children | Cirrhosis | Gastroenterology | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | Liver Disease | Urology & Nephrology